A comprehensive view of capsules / pills / tablets. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Ascend Labs recalls 10 lots of dabigatran etexilate anticoagulant capsules in US after routine test finds suspected carcinogen N-nitroso-dabigatran; products shipped between June 2022 and October 2022

Pfizer recalls 4.2 million units of prescription Nurtec ODT 75 mg orally disintegrating migraine therapy tablets sold in cartons containing one blister card of 8 tablets; drug package does not meet child-resistant packaging requirements

FDA briefing document finds clinical trial results of Pfizer’s Paxlovid COVID-19 antiviral pill support drug’s use in high-risk adults; FDA meeting Thursday to discuss recommending full approval of Paxlovid as COVID-19 treatment

Dr Reddy's Laboratories recalling 4,320 bottles of Tacrolimus Capsules in the US due to ‘Presence of one Tacrolimus 1 mg capsule co-mingled in a bottle containing and labeled as Tacrolimus 0.5 mg capsules,’ according to FDA enforcement report

Janssen submits NDA to the US FDA seeking approval of niraparib and abiraterone acetate dual-action tablet, plus prednisone, as a first-line targeted treatment for patients with BRCA-positive metastatic castration-resistant prostate cancer

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count